Application 074476
- Type
- ANDA
- Sponsor
- ROXANE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HYDROXYUREA | HYDROXYUREA | CAPSULE;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074476-001 | HYDROXYUREA | HYDROXYUREA | 500MG | CAPSULE / ORAL | 1995-08-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A074476-001 | HYDROXYUREA | 500MG | CAPSULE / ORAL | 1995-08-18 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074476-001 | HYDROXYUREA | 500MG | CAPSULE / ORAL | 1995-08-18 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074476-001 | HYDROXYUREA | 500MG | CAPSULE / ORAL | 1995-08-18 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyurea | HYDROXYUREA | Major Pharmaceuticals | e76fd60e-7644-48c5-9857-3608a045000b | 2026-05-27 | Warnings, Adverse reactions | Hydroxyurea HYDROXYUREA |
| Hydroxyurea | HYDROXYUREA | Par Health USA, LLC | 9e1bdd4b-043a-4cf6-b1ff-8de49e02b7a6 | 2026-05-07 | Warnings, Adverse reactions | Hydroxyurea HYDROXYUREA |
| Hydroxyurea | HYDROXYUREA | American Health Packaging | c84a2241-6c05-480f-8a5b-049e08c27d73 | 2026-03-02 | Warnings, Adverse reactions | Hydroxyurea HYDROXYUREA |
| XROMI | HYDROXYUREA | Nova Laboratories, Ltd. | 4b37d336-86da-4363-aef1-34a7d3ba973b | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | HYDROXYUREA |
| HYDREA | HYDROXYUREA | H2-Pharma LLC | 6053c775-68de-45e4-9af9-33b18fd0e140 | 2026-01-26 | Warnings, Adverse reactions | HYDROXYUREA |
| DROXIA | HYDROXYUREA | H2-Pharma LLC | a9494409-3571-4a81-9ad3-15ef7cb636a2 | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | HYDROXYUREA |
| Siklos | HYDROXYUREA | Medunik | 76957c0d-0f98-4376-bb06-eee651adc09d | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | Coupler LLC | 44fd5379-5fb0-ff62-e063-6294a90ac792 | 2025-12-02 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | AvKARE | 862583ff-6d5c-3f7d-e3bd-352fb0400928 | 2025-10-15 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
| HYDREA | HYDROXYUREA | Waylis Therapeutics LLC | 8d41152f-a98a-4abc-afdf-a909012434a0 | 2025-09-15 | Warnings, Adverse reactions | HYDROXYUREA |
| DROXIA | HYDROXYUREA | Waylis Therapeutics LLC | 4ad13dc6-a2ab-4308-96b3-7c642c92cc23 | 2025-09-12 | Boxed warning, Warnings, Adverse reactions | HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | Golden State Medical Supply, Inc. | 1b42f2b4-3880-e7a9-e063-6294a90a5fd0 | 2024-11-25 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | Leading Pharma, LLC | 4c4e1c2f-2143-44f3-8825-aeba42e755e4 | 2024-10-29 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | Somerset Therapeutics, LLC | 9752a347-b42c-44d5-8fd1-c538f7f239dc | 2024-09-23 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | Teva Pharmaceuticals USA, Inc. | b9514ae5-79ae-4cc2-9d7f-c8f7806d1694 | 2024-05-30 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
| HYDROXYUREA | HYDROXYUREA | Qilu Pharmaceutical Co., Ltd. | 4cd244d4-bd4a-41c8-b072-c2135787d412 | 2024-04-30 | Warnings, Adverse reactions | HYDROXYUREA HYDROXYUREA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.